Alembic Pharmaceuticals Limited
NSE: APLLTD.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chirayu Ramanbhai Amin
- Employees
- 14,858
- Headquarters
- Vadodara, India
- IPO year
- 2011
- Market cap
- ₹154.7B
- Website
- https://alembicpharmaceuticals.com
Loading APLLTD…
Loading profile data…Frequently asked questions about APLLTD
What does Alembic Pharmaceuticals Limited (APLLTD.NS) do?
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, ne...
Where does APLLTD.NS trade?
Alembic Pharmaceuticals Limited (APLLTD.NS) trades on the National Stock Exchange of India.
What sector is APLLTD.NS in?
Alembic Pharmaceuticals Limited (APLLTD.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Alembic Pharmaceuticals Limited?
Chirayu Ramanbhai Amin is the chief executive officer of Alembic Pharmaceuticals Limited (APLLTD.NS).
Where is Alembic Pharmaceuticals Limited headquartered?
Alembic Pharmaceuticals Limited is headquartered in India.
Does APLLTD.NS pay a dividend?
Yes — Alembic Pharmaceuticals Limited (APLLTD.NS) paid a trailing twelve-month dividend of INR 11.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did APLLTD.NS go public?
Alembic Pharmaceuticals Limited (APLLTD.NS) completed its initial public offering in 2011.